Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease

PLoS Pathogens

Volumn 8, Issue 6, 2012, Pages

  Anuradha, R ^a   George, P Jovvian ^a   Kumar, N Pavan ^a   Fay, Michael P ^b   Kumaraswami, V ^c   Nutman, Thomas B ^b   Babu, Subash ^a,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 2 MACROGLOBULIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; CYTOKINE; HAPTOGLOBIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; CARRIER PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRUGIA MALAYI; CONTROLLED STUDY; DISEASE MARKER; ELEPHANTIASIS; FEMALE; HUMAN; HYDROCELE; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; LYMPHATIC FILARIASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; WUCHERERIA BANCROFTI; BLOOD; IMMUNOLOGY; MIDDLE AGED;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; CARRIER PROTEINS; CYTOKINES; ELEPHANTIASIS, FILARIAL; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; YOUNG ADULT;

EID: 84864032907     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002749     Document Type: Article

References (39)

1. Nutman TB, Kumaraswami V, (2001) Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India. Parasite Immunol 23: 389-399.
2. Dreyer G, Noroes J, Figueredo-Silva J, Piessens WF, (2000) Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today 16: 544-548.
3. de Almeida AB, Freedman DO, (1999) Epidemiology and immunopathology of bancroftian filariasis. Microbes Infect 1: 1015-1022.
4. Steel C, Ottesen EA, Weller PF, Nutman TB, (2001) Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. Am J Trop Med Hyg 65: 498-503.
5. Babu S, Anuradha R, Pavan Kumar N, George PJ, Kumaraswami V, et al. (2011) Filarial Lymphatic Pathology Reflects Augmented TLR-mediated, MAPK-mediated Pro-inflammatory Cytokine Production. Infect Immun 79: 4600-4608.
6. Babu S, Bhat SQ, Pavan Kumar N, Lipira AB, Kumar S, et al. (2009) Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl Trop Dis 3: e420.
7. Pfarr KM, Debrah AY, Specht S, Hoerauf A, (2009) Filariasis and lymphoedema. Parasite Immunol 31: 664-672.
8. Freedman DO, Plier DA, de Almeida A, Miranda J, Braga C, et al. (1999) Biased TCR repertoire in infiltrating lesional T cells in human Bancroftian filariasis. J Immunol 162: 1756-1764.
9. Lawrence RA, Devaney E, (2001) Lymphatic filariasis: parallels between the immunology of infection in humans and mice. Parasite Immunol 23: 353-361.
10. Nixon DE, Landay AL, (2010) Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 5: 498-503.
11. Medzhitov R, (2007) Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
12. Bennuru S, Nutman TB, (2009) Lymphatics in human lymphatic filariasis: in vitro models of parasite-induced lymphatic remodeling. Lymphat Res Biol 7: 215-219.
13. Chakera A, Lucas A, Lucas M, (2011) Surrogate markers of infection: interrogation of the immune system. Biomark Med 5: 131-148.
14. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, et al. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635.
15. Leeto M, Herbert DR, Marillier R, Schwegmann A, Fick L, et al. (2006) TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis. Am J Pathol 169: 1701-1712.
16. Robinson MW, Donnelly S, Hutchinson AT, To J, Taylor NL, et al. (2011) A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog 7: e1002042.
17. Farid AS, Jimi F, Inagaki-Ohara K, Horii Y, (2008) Increased intestinal endotoxin absorption during enteric nematode but not protozoal infections through a mast cell-mediated mechanism. Shock 29: 709-716.
18. McDermott JR, Bartram RE, Knight PA, Miller HR, Garrod DR, et al. (2003) Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci U S A 100: 7761-7766.
19. Ferraz AA, Campos JM, Junior JG, De Albuquerque AC, Ferraz EM, (2005) Gut bacterial translocation and postoperative infections: a prospective study in schistosomotic patients. Surg Infect (Larchmt) 6: 197-201.
20. Figueredo-Silva J, Noroes J, Cedenho A, Dreyer G, (2002) The histopathology of bancroftian filariasis revisited: the role of the adult worm in the lymphatic-vessel disease. Ann Trop Med Parasitol 96: 531-541.
21. Olszewski W, Jamal S, (1994) Skin bacterial factor in progression of filarial lymphedema. Lymphology 27: 148-149.
22. Olszewski WL, Jamal S, Manokaran G, Pani S, Kumaraswami V, et al. (1997) Bacteriologic studies of skin, tissue fluid, lymph, and lymph nodes in patients with filarial lymphedema. Am J Trop Med Hyg 57: 7-15.
23. Olszewski WL, Jamal S, Manokaran G, Pani S, Kumaraswami V, et al. (1999) Bacteriological studies of blood, tissue fluid, lymph and lymph nodes in patients with acute dermatolymphangioadenitis (DLA) in course of 'filarial' lymphedema. Acta Trop 73: 217-224.
24. Swoboda-Kopec E, Luczak M, Lukomska B, Olszewski WL, Jamal S, et al. (1999) [Bacterial infections of skin and soft tissues in filariasis]. Med Dosw Mikrobiol 51: 347-355.
25. Kitchens RL, Thompson PA, (2005) Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 11: 225-229.
26. Cohen IR, Norins LC, (1966) Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M. Science 152: 1257-1259.
27. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
28. Nowroozalizadeh S, Mansson F, da Silva Z, Repits J, Dabo B, et al. (2010) Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis 201: 1150-1154.
29. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, et al. (2011) Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection. Gastroenterology 141: 1220-30.
30. Onguru D, Liang Y, Griffith Q, Nikolajczyk B, Mwinzi P, et al. (2011) Human schistosomiasis is associated with endotoxemia and Toll-like receptor 2- and 4-bearing B cells. Am J Trop Med Hyg 84: 321-324.
31. Baumann H, Gauldie J, (1990) Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7: 147-159.
32. Johnson HL, Chiou CC, Cho CT, (1999) Applications of acute phase reactants in infectious diseases. J Microbiol Immunol Infect 32: 73-82.
33. Peracaula R, Sarrats A, Rudd PM, (2010) Liver proteins as sensor of human malignancies and inflammation. Proteomics Clin Appl 4: 426-431.
34. Levels JH, Geurts P, Karlsson H, Maree R, Ljunggren S, et al. (2011) High-density lipoprotein proteome dynamics in human endotoxemia. Proteome Sci 9: 34.
35. Lal RB, Dhawan RR, Ramzy RM, Farris RM, Gad AA, (1991) C-reactive protein in patients with lymphatic filariasis: increased expression on lymphocytes in chronic lymphatic obstruction. J Clin Immunol 11: 46-53.
36. Satapathy AK, Sartono E, Sahoo PK, Dentener MA, Michael E, et al. (2006) Human bancroftian filariasis: immunological markers of morbidity and infection. Microbes Infect 8: 2414-2423.
37. Turner PF, Rockett KA, Ottesen EA, Francis H, Awadzi K, et al. (1994) Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis. J Infect Dis 169: 1071-1075.
38. Pang WW, Abdul-Rahman PS, Wan-Ibrahim WI, Hashim OH, (2010) Can the acute phase reactant proteins be used as cancer biomarkers? Int J Biol Markers 25: 1-11.
39. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A, (2011) Immunological biomarkers of tuberculosis. Nat Rev Immunol 11: 343-354.